The approval of a new gene therapy to treat spinal muscular atrophy has created a hot debate in the health policy world about whether or not the drug's $2.1 million price tag is too expensive or a fair price. More
While we rush to fix the opioid crisis, are we ignoring another widespread drug problem? More
A group of pharmacists from Lifespan/Rhode Island Hospital answer our questions about how pharmacists can promote deprescribing. More
Is our health care system prepared to treat more behavioral health problems in younger people? So far, the answer is no. More
Health care experts explain the potential downsides to the artificial intelligence "revolution." More
In Health Affairs Grantwatch blog, Shannon Brownlee and Terry Fulmer describe how the Lown Institute and John A. Hartford Foundation are working together to reduce medication overload. More
Popular health news often fails to reflect the incrementalism and nuance of medical discoveries, instead hyping unproven treatments. Can we save health journalism? More
Much of the political discourse around health focuses on expanding access to health insurance. But how much does health care really matter for health? More
When we think of initiatives to improve health care value, we generally think of policies to reduce volume or price. But what if there was another way to improve the bang for each health care buck? More
Physician practices are increasingly being bought up by private equity firms. What does this mean for quality of care and overuse? More
Why is palliative care still underutilized, despite the improvements in quality of life it offers patients with serious illness? More
Solutions for increasing racial and gender equity in health care, from the Atlantic Pulse conference. More
A new study in JAMA shows how often cardiovascular trials contain misleading information... More
Clinicians and public health experts are calling attention to the health risks and financial implications of widespread loneliness. More
At the Atlantic Pulse conference, health care experts proposed several "fixes" for the medical education system. More
Why is the culture the drives overprescribing so tough to change? Read the new op-ed from Theresa Brown, RN, to find out more! More
Social media has become the newest form of direct-to-consumer health advertising... but for what benefit? More
Dr. Brandon Combs is Associate Professor of Medicine at the University of Colorado and a Deprescribing Champion! Read our interview with Dr. Combs here. More
Why the revolving door poses a serious problem for government agency regulation. More
A recent study in JAMA Internal Medicine examines how well clinicians in the ICU incorporate patients’ values into treatment decisions. More